Pyridostigmine bromide
SIGMA/P9797
Synonym: 3-
CAS Number: 101-26-8
Empirical Formula (Hill Notation): C9H13BrN2O2
Molecular Weight: 261.12
EC Number: 202-929-9
MDL Number: MFCD00079283
Linear Formula: C9H13BrN2O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | solid |
| InChI | 1S/C9H13N2O2.BrH/c1-10(2) |
| InChI key | VNYBTNPBYXSMOO-UHFFFAOYSA |
| originator | Valeant |
| Quality Level | 100  |
| SMILES string | [Br-].CN(C)C(=O)Oc1ccc[n+ |
| solubility | water: 100 mg/mL, clear to very slightly hazy, colorless |
| Application: | Pyridostigmine bromide has been used as a cholinesterase inhibitor in mice, in florimetric assay for acetylcholine secretion and for measuring acetylcholine release from mice atrial tissue. |
| Biochem/physiol Actions: | Acetylcholinesterase inhibitor. |
| Biochem/physiol Actions: | Pyridostigmine bromide inhibits acetylcholine esterase and is membrane impermeable. It is used as a preventive medicine in chemical warfare. Pyridostigmine bromide is a carbamate compound comprising quaternary amine structure. It displays low absorption at the gastrointestinal tract. Sustained release of pyridostigmine is recommended for improving its bioavailability in treating myasthenia gravis. |
| Features and Benefits: | This compound was developed by Valeant . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 g in glass bottle |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H300 + H310 + H330 - H317 |
| Precautionary statements | P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P304 + P340 + P310 |
| Hazard Codes | T+ |
| Risk Statements | 26/27/28-43 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |